Atar Funda, Gedik Ender, Kaplan Şerife, Zeyneloğlu Pınar, Pirat Arash, Haberal Mehmet
From the Department of Anesthesiology and Reanimation, Başkent University Faculty of Medicine, Ankara, Turkey.
Exp Clin Transplant. 2015 Nov;13 Suppl 3:15-21. doi: 10.6002/ect.tdtd2015.O10.
We evaluated late intensive care unit admission in liver transplant recipients to identify incidences and causes of acute respiratory failure in the postoperative period and to compare these results with results in patients who did not have acute respiratory failure.
We retrospectively screened the data of 173 consecutive adult liver transplant recipients from January 2005 through March 2015 to identify patients with late admission (> 30 d posttransplant) to an intensive care unit. Patients were divided into 2 groups: patients with and without acute respiratory failure. Acute respiratory failure was defined as severe dyspnea, respiratory distress, decreased oxygen saturation, hypoxemia or hypercapnia on room air, or need for noninvasive or invasive mechanical ventilation. Demographic, laboratory, clinical, and respiratory data were collected. Model for End-Stage Liver Disease, Acute Physiology and Chronic Health Evaluation II, and Sequential Organ Failure Assessment scores; lengths of intensive care unit and hospital stays; and hospital mortality were assessed.
Among 173 patients, 37 (21.4%) were admitted to an intensive care unit, including 22 (59.5%) with acute respiratory failure. The leading cause of acute respiratory failure was pneumonia (n = 19, 86.4%). Patients with acute respiratory failure had significantly lower levels of albumin before intensive care unit admission (P = .003). In patients with acute respiratory failure, severe sepsis and septic shock were more frequently observed and tracheotomy was more frequently performed (P = .041).
Acute respiratory failure developed in 59.5% of liver transplant recipients with late intensive care unit admission. The leading cause was pneumonia, with this group of patients having higher requirements for invasive mechanical ventilation and tracheotomy, longer stays in an intensive care unit, and higher mortality.
我们评估了肝移植受者晚期入住重症监护病房的情况,以确定术后急性呼吸衰竭的发生率和原因,并将这些结果与未发生急性呼吸衰竭的患者的结果进行比较。
我们回顾性筛查了2005年1月至2015年3月期间173例连续的成年肝移植受者的数据,以确定晚期(移植后>30天)入住重症监护病房的患者。患者分为两组:发生急性呼吸衰竭的患者和未发生急性呼吸衰竭的患者。急性呼吸衰竭定义为严重呼吸困难、呼吸窘迫、氧饱和度降低、在室内空气中出现低氧血症或高碳酸血症,或需要无创或有创机械通气。收集了人口统计学、实验室、临床和呼吸数据。评估了终末期肝病模型、急性生理学和慢性健康状况评估II以及序贯器官衰竭评估评分;重症监护病房和住院时间;以及医院死亡率。
在173例患者中,37例(21.4%)入住了重症监护病房,其中22例(59.5%)发生急性呼吸衰竭。急性呼吸衰竭的主要原因是肺炎(n = 19,86.4%)。发生急性呼吸衰竭的患者在入住重症监护病房前白蛋白水平显著较低(P = .003)。在发生急性呼吸衰竭的患者中,更频繁地观察到严重脓毒症和感染性休克,并且更频繁地进行气管切开术(P = .041)。
59.5%的晚期入住重症监护病房的肝移植受者发生了急性呼吸衰竭。主要原因是肺炎,这组患者对有创机械通气和气管切开术的需求更高,在重症监护病房的住院时间更长,死亡率更高。